Evidence map›Paper›PMID 25212064›Full record

ArticleWorld journal of surgery2015

Implementing an enhanced recovery program after pancreaticoduodenectomy in elderly patients: is it feasible?

Mariëlle M E Coolsen, Maikel Bakens, Ronald M van Dam, Steven W M Olde Damink, Cornelis H C Dejong

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in World journal of surgery, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02941484 (A Prospective, Randomized Trial of Early Oral Intake After Pancreaticoduodenectomy in the Age of ERAS), which is not on this map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02941484 naunknown statusnot on this mapstarted 2016, after this paper: background citation

A Prospective, Randomized Trial of Early Oral Intake After Pancreaticoduodenectomy in the Age of ERAS

TypeinterventionalSponsorXuzhou Medical UniversityRan2016 to 2019Enrolled100ConditionsPeriampullary Carcinoma Resectable, PancreaticoduodenectomyArmsearly oral intake, jejunostomy tube feeding (JTF)
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. ERAS, length of stay and private insurance: a retrospective study.International journal of colorectal disease · 2019
    Article
  11. Article
  12. Evaluation of an enhanced recovery protocol after pancreaticoduodenectomy in elderly patients.HPB : the official journal of the International Hepato Pancreato Biliary Association · 2016
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mariëlle M E CoolsenDepartment of Surgery, University Hospital Maastricht, PO Box 5800, 6202 AZ, Maastricht, The Netherlands, marielle.coolsen@maastrichtuniversity.nl.
Maikel Bakens
Ronald M van Dam
Steven W M Olde Damink
Cornelis H C Dejong
Maastricht University Medical Centre · NLMaastricht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn enhanced recovery after surgery (ERAS) program aims to reduce the stress response to surgery and thereby accelerate recovery. It is unclear whether these programs can be safely implemented for elderly patients, especially in highly complex surgery such as pancreaticoduodenectomy (PD). The objective of this study was to evaluate the feasibility of an ERAS program in elderly patients undergoing PD.

methodsImplementation of the ERAS protocol was studied prospectively in a consecutive series of patients undergoing PD between January 2009 and August 2013. Patients were divided into two groups: ≤ 65 years and ≥ 70 years. Endpoints were length of stay (LOS), readmissions, morbidity, mortality, and compliance with ERAS targets.

resultsOf a total of 110 patients, 55 were ≤ 65 years (median 57) and 55 ≥ 70 years (median 77). Median LOS was 14 days in both groups. In patients without complications median LOS was 9 days. Both mortality and readmissions did not differ between groups (mortality n = 3 (5.5 %) in younger versus n = 6 (10.9 %) in older patients, p = 0.49, readmissions: n = 11 (20 %) versus n = 7 (12.7 %), p = 0.44). CT-drainage and relaparotomy-rates were not different between groups, nor was overall morbidity (n = 31 (56.3 %) in the older versus n = 35 (63.3 %) in the younger group, p = 0.44). There were no differences in compliance with elements of the ERAS protocol between groups.

conclusionAn ERAS program seems feasible and safe for patients ≥ 70 years of age undergoing PD.

Indexed as

PancreaticoduodenectomyPostoperative CareRecovery of FunctionAgedAged, 80 and overFeasibility StudiesFemaleHumansLength of StayMalePatient ReadmissionPostoperative ComplicationsProspective Studies

Identifiers

PMID25212064
OpenAlexW2159057085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.